Biomarker Research
eISSN: 2050-7771pISSN: 2050-7771
Open AccessShare this on:
Key Metrics
CiteScore 
7
Eigenfactor
0.001 - 0.005
Impact Factor
5 - 10
SJR
Q1Molecular Medicine
SNIP
1
Topics Covered
Myeloid leukemia
Reactive oxygen species
Breast cancer
Mesothelioma
Immunotherapy
Serum protein
Anticoagulant
Human cancer
Chimeric antigen receptor
MEK inhibitor
Neurofilament light
Neurofibromatosis
Annexin
Bone marrow
Overall survival
Bile acid
Esophageal squamous cell carcinoma
Extracellular vesicles
Tumor microenvironment
Retrospective analysis
Journal Specifications
Indexed in the following public directories
Scopus 
DOAJ 
Web of Science
Overview
- PublisherSpringer Nature
- LanguageEnglish
- FrequencyContinuous publication
- Article Processing ChargesGBP 2090 | USD 3090
- Publication Time10
- Editorial Review ProcessBlind peer review
General Details
- LanguageEnglish
- FrequencyContinuous publication
- Publication Start Year2013
- Publisher URL
- Website URL
Publication Details
- Plagiarism
- Publication Time10
- Waiver Policy
Editorial Review Detail
- Editorial Team
- Review ProcessBlind peer review
- Review Url
- Author instructions
- Copyright Details
- Deposit PolicySherpa/Romeo
- License typeCC BY, CC0
- OA statement
View less
Planning to publish in Biomarker Research ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers
HER2-targeted advanced metastatic gastric/gastroesophageal junction adenocarcinoma: treatment landscape and future perspectives
- 30 Sep 2022
- Biomarker Research
METTL1 promotes neuroblastoma development through m7G tRNA modification and selective oncogenic gene translation.
- 7 Sep 2022
- Biomarker research
Advances in molecular biomarkers research and clinical application progress for gastric cancer immunotherapy.
- 30 Aug 2022
- Biomarker research
Impact of NSCLC metabolic remodeling on immunotherapy effectiveness.
- 29 Aug 2022
- Biomarker research
Long noncoding RNA HOXC-AS3 interacts with CDK2 to promote proliferation in hepatocellular carcinoma.
- 28 Aug 2022
- Biomarker research
Physio-pathological effects of N6-methyladenosine and its therapeutic implications in leukemia.
- 23 Aug 2022
- Biomarker research
HER2-targeted advanced metastatic gastric/gastroesophageal junction adenocarcinoma: treatment landscape and future perspectives
- 30 Sep 2022
- Biomarker Research
METTL1 promotes neuroblastoma development through m7G tRNA modification and selective oncogenic gene translation.
- 7 Sep 2022
- Biomarker research
Advances in molecular biomarkers research and clinical application progress for gastric cancer immunotherapy.
- 30 Aug 2022
- Biomarker research
Impact of NSCLC metabolic remodeling on immunotherapy effectiveness.
- 29 Aug 2022
- Biomarker research
Long noncoding RNA HOXC-AS3 interacts with CDK2 to promote proliferation in hepatocellular carcinoma.
- 28 Aug 2022
- Biomarker research
Physio-pathological effects of N6-methyladenosine and its therapeutic implications in leukemia.
- 23 Aug 2022
- Biomarker research
FAQs
How long has Biomarker Research been actively publishing? 
Biomarker Research has been in operation since 2013 till date.
What is the publishing frequency of Biomarker Research?
Biomarker Research published with a Continuous publication frequency.
How many articles did Biomarker Research publish last year?
In 2022, Biomarker Research publsihed 15 articles.
What is the eISSN & pISSN for Biomarker Research?
For Biomarker Research, eISSN is 2050-7771 and pISSN is 2050-7771.
What is Citescore for Biomarker Research?
Citescore for Biomarker Research is 7.
What is SNIP score for Biomarker Research?
SNIP score for Biomarker Research is 1.
What is the SJR for Biomarker Research?
SJR for Biomarker Research is Q1.
Who is the publisher of Biomarker Research?
Springer Nature is the publisher of Biomarker Research.